About Us

Pharmaxyn Laboratories Ltd.

Pharmaxyn, set up in 2007, is engaged in R&D, manufacture and marketing of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. All the research and production activities are carried out under cGMP focusing on the therapeutic areas of anti-diabetic, anti-virus and cardiovascular drugs.

Voglibose was the first product launched ever since company’s establishment, and pharmaxyn is the largest producer of voglibose and its intermediates with high purity and competitive price in China.

With world class state of art manufacturing facility and professional team, we undertake projects for developing advanced pharmaceutical intermediates, APIs with complete analytical back-up. Production scales could start from grams to multi-tons, which can meet different client needs from preclinical to commercial stages.

Pharmaxyn is certificated as Provincial Hi-Tech Enterprise and has obtained the Accreditation of Foreign Drug Manufacturer in Japan, ISO9001:2008 Certificate, ISO14001:2004 Certificate and Drug Manufacturing License in China.

nnovation plays a very important role in daily work in Pharmaxyn. A number of patents for the main products, such as Voglibose have been assigned in China, Korea and Japan. Nowadays, Pharmaxyn won high reputation and became a reliable business partner for many famous companies in the world.